Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Sun Biopharma, Inc. (SNBP)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sun Biopharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Sun Biopharma, Inc. since 2005.
The reporting company's ticker symbol is SNBP. The reporting company's CIK number is 1029125.
The total value of stock buying since 2005 is $20,010.
The total value of stock sales since 2005 is $2,559,891.
The total value of stock option exercises since 2005 is $150,000.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-30||Cullen Michael T. (Exec. Chairman, Pres. & CEO)||Buy||30,000||.00||0|
|2019-08-30||Horvath Susan (V.P. of Finance & CFO)||Buy||1,428||.00||0|
|2019-08-16||Gilbertson Ryan Randall (10% Owner)||Sale||343,411||3.00||1,030,233|
|2018-08-15||Gilbertson Ryan Randall (10% Owner)||Sale||47,025||.00||0|
|2018-05-16||Schaffer Paul W. (Director)||Buy||5,000||.00||0|
|2018-05-16||Kaysen David B (President and CEO)||Buy||1,000||.00||0|
|2018-02-20||Cullen Michael T. (Executive Chairman)||Buy||5,000||.00||0|
|2018-02-20||Mathiesen Jeffrey S (Director)||Buy||3,000||.00||0|
|2017-12-13||Gilbertson Ryan Randall (10% Owner)||Option Ex||80,000||1.88||150,000|
|2016-11-14||Schemel Donald Robert (Director)||Sale||7,000||1.43||10,010|
|2016-06-24||Cullen Michael T. (Executive Chairman)||Buy||50,000||.00||0|
|2016-06-24||Gagnon Suzanne (Director)||Buy||30,000||.00||0|
|2016-06-24||Schaffer Paul W. (Director)||Buy||100,000||.00||0|
|2016-06-24||Kellen Scott (Chief Financial Officer)||Buy||35,000||.00||0|
|2016-06-24||Kaysen David B (President and CEO)||Buy||50,000||.00||0|
|2015-09-01||Sargent Robert John||Sale||216,705||.00||0|
|2015-09-01||Fuhrman David Michael||Sale||300,561||.00||0|
|2015-03-01||Sargent Robert John||Buy||100,059||.10||10,005|
|2015-03-01||Fuhrman David Michael (President and CEO)||Buy||100,059||.10||10,005|
|2002-05-01||Sargent Robert John||Sale||42,756||13.54||578,916|
|2002-05-01||Fuhrman David Michael (President and CEO)||Sale||69,478||13.54||940,732|
Insider trading activities including stock purchases, stock sales, and option exercises of SNBP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sun Biopharma, Inc. (symbol SNBP, CIK number 1029125) see the Securities and Exchange Commission (SEC) website.